ACARVIB M50ACARBOSE 50mg. IP + METFORMIN 500mg. IP

Acarvib M50 tablets with Acarbose 50 mg and Metformin 500 mg for blood sugar control in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve glycemic (blood sugar) control in adults with type 2 diabetes mellitus; helps lower the rise in blood sugar after meals; used when diet and exercise alone do not keep blood sugar in range.

Common side effects of Acarvib M50 Tablet include flatulence (gas in the abdomen); diarrhoea; abdominal pain; bloating; nausea; vomiting. Get medical help at once if you notice lactic acidosis with metformin (malaise, muscle pain, breathing difficulty, drowsiness, abdominal pain; needs urgent care); severe low blood sugar when used with insulin or other antidiabetic medicines; raised liver enzymes or hepatitis with acarbose; liver function should be monitored.

Each Acarvib M50 tablet contains Acarbose 50 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Acarvib M50 Tablet only as your doctor advises.

The MRP of Acarvib M50 Tablet is ₹149 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹113.52 and the PTS is ₹102.17.

Each Acarvib M50 tablet contains Acarbose 50 mg + Metformin 500 mg. It comes in a pack of 10x10 (Alu Alu).

Inside the tablet, acarbose blocks the enzymes in the small intestine that break down complex carbohydrates and sugars into glucose. Because the breakdown is slowed, glucose is absorbed gradually and the blood sugar level rises less sharply after meals. Metformin, a biguanide, acts in a different way: it lowers the amount of glucose produced by the liver and helps the body respond to insulin. The two work along separate paths, so the tablet acts on both the after-meal rise and the overall blood sugar level through the day.

Must not be used if you are allergic to acarbose or metformin or to any ingredient of the tablet. Must not be used in diabetic ketoacidosis or other metabolic acidosis. Must not be used if you have severe kidney impairment (eGFR below 30 mL/min/1.73 m2). Must not be used in cirrhosis, inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, a tendency to intestinal obstruction, chronic intestinal diseases with marked disorders of digestion or absorption, or conditions that may worsen from increased gas in the intestine. Check with a doctor first if you have kidney or liver problems, drink excess alcohol, are aged 65 or above, need contrast X-ray studies or surgery, have type 1 diabetes, or take insulin or other blood sugar-lowering medicines.

Acarvib M50 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.